Big Pharma's strategic push into biologics and continuing restructuring are among the highlights for 2007.
Link to Article
Pharmtech.com
|
|
||||
|
This Month
Month Archive
RSS Newsfeeds
Main Page RSS
|
Wednesday, December 5
2007: The Year in Review
by
Alex Hsieh on behalf of Professor Henry Wang
on Wed 05 Dec 2007 11:44 PM EST
2007 Ends with a Drought in New Molecular Entities
by
Alex Hsieh on behalf of Professor Henry Wang
on Wed 05 Dec 2007 11:43 PM EST
The number of new molecular entities approved by the US Food and Drug Administration is down this year as the pharmaeutical industry continues to face an innovation drought.
Link to Article Pharmtech.com
A FDA Perspective on Quality by Design
by
Alex Hsieh on behalf of Professor Henry Wang
on Wed 05 Dec 2007 11:42 PM EST
Chi-wan Chen, deputy director of the Office of New Drug Quality Assessment (ONDQA) at the US Food and Drug Administration's Center for Drug Evaluation and Research, shares insight from FDA's pilot program that was designed to allow pharmaceutical companies to submit CMC information demonstrating application of quality by design.
Link to Article Pharmtech.com
Empowering FDA
by
Alex Hsieh on behalf of Professor Henry Wang
on Wed 05 Dec 2007 11:40 PM EST
A new law gives more powers to the regulatory agency and will impact the drug industry for years
The Food & Drug Administration overhaul bill signed into law in September is one of the most wide-ranging revisions of the federal Food, Drug & Cosmetic Act passed in 40 years and is likely to affect the pharmaceutical industry for decades to come. Link to Article Chemical & Engineering News
Drug Companies Cut Costs
by
Alex Hsieh on behalf of Professor Henry Wang
on Wed 05 Dec 2007 11:39 PM EST
In the midst of rapidly changing global markets, firms aggressively reduce spending to protect profitability
This year, pharmaceutical companies have wielded cost-cutting measures like a powerful weapon to combat antagonistic pressures that threaten to ravage their profitability. Link to Article Chemical & Engineering News
Combo products need guidelines
by
Alex Hsieh on behalf of Professor Henry Wang
on Wed 05 Dec 2007 11:37 PM EST
05/12/2007 - The combination products market is zooming ahead, requiring the need to address regulatory challenges, an author of a white paper says.
Link to Article in-pharmatechnologist.com
NanoBiotech Will Bloom In 2007
by
Alex Hsieh on behalf of Professor Henry Wang
on Wed 05 Dec 2007 11:36 PM EST
As we begin the final month of 2006, now is a good time to survey the landscape in nanobiotech and see what investors can look forward to in 2007.
Link to Article Forbes.com |
Search
Links
|
||